Michael Zuscik
Concepts (535)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoarthritis | 25 | 2025 | 167 | 5.790 |
Why?
| Chondrocytes | 45 | 2021 | 203 | 3.810 |
Why?
| Cartilage, Articular | 18 | 2021 | 292 | 2.280 |
Why?
| Transforming Growth Factor beta | 23 | 2014 | 457 | 1.820 |
Why?
| Chondrogenesis | 10 | 2016 | 82 | 1.310 |
Why?
| Gastrointestinal Microbiome | 3 | 2025 | 641 | 1.280 |
Why?
| Fracture Healing | 6 | 2014 | 75 | 1.170 |
Why?
| Menisci, Tibial | 3 | 2021 | 59 | 1.150 |
Why?
| Cell Differentiation | 33 | 2018 | 1902 | 1.100 |
Why?
| Joints | 3 | 2025 | 100 | 1.070 |
Why?
| Osteoarthritis, Knee | 6 | 2023 | 240 | 1.030 |
Why?
| Bone Morphogenetic Proteins | 15 | 2008 | 131 | 0.980 |
Why?
| Growth Plate | 8 | 2013 | 36 | 0.950 |
Why?
| Cartilage | 12 | 2021 | 180 | 0.840 |
Why?
| Lead | 6 | 2014 | 56 | 0.830 |
Why?
| Animals | 101 | 2025 | 35361 | 0.820 |
Why?
| Mice | 65 | 2021 | 16937 | 0.810 |
Why?
| Osteogenesis | 13 | 2018 | 175 | 0.780 |
Why?
| Obesity | 10 | 2018 | 2883 | 0.770 |
Why?
| Disease Models, Animal | 18 | 2021 | 4063 | 0.770 |
Why?
| Receptors, Adrenergic, alpha-1 | 8 | 2003 | 43 | 0.720 |
Why?
| Dysbiosis | 2 | 2020 | 169 | 0.720 |
Why?
| Joint Diseases | 1 | 2021 | 56 | 0.710 |
Why?
| Wounds and Injuries | 3 | 2019 | 711 | 0.710 |
Why?
| Diet, High-Fat | 6 | 2018 | 239 | 0.700 |
Why?
| Knee Injuries | 2 | 2021 | 99 | 0.680 |
Why?
| Inflammation | 5 | 2020 | 2736 | 0.680 |
Why?
| Signal Transduction | 34 | 2021 | 4925 | 0.670 |
Why?
| Smad3 Protein | 6 | 2012 | 43 | 0.650 |
Why?
| Mice, Inbred C57BL | 26 | 2019 | 5440 | 0.640 |
Why?
| beta Catenin | 11 | 2016 | 223 | 0.630 |
Why?
| Collagen Type I | 2 | 2017 | 119 | 0.550 |
Why?
| Dietary Supplements | 2 | 2021 | 534 | 0.540 |
Why?
| Microbiota | 1 | 2025 | 730 | 0.540 |
Why?
| Cells, Cultured | 31 | 2018 | 4083 | 0.530 |
Why?
| Bony Callus | 3 | 2014 | 6 | 0.500 |
Why?
| Bone Morphogenetic Protein 2 | 15 | 2014 | 63 | 0.500 |
Why?
| Diabetes Mellitus, Type 2 | 8 | 2018 | 2441 | 0.490 |
Why?
| Core Binding Factor Alpha 1 Subunit | 8 | 2019 | 39 | 0.480 |
Why?
| Teriparatide | 2 | 2011 | 6 | 0.470 |
Why?
| NF-kappa B | 5 | 2021 | 653 | 0.440 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 6 | 2009 | 133 | 0.440 |
Why?
| Dinoprostone | 5 | 2009 | 186 | 0.420 |
Why?
| Erythropoietin | 2 | 2017 | 86 | 0.410 |
Why?
| Neuroprotective Agents | 2 | 2016 | 122 | 0.400 |
Why?
| Osteoclasts | 7 | 2015 | 42 | 0.400 |
Why?
| Collagen Type X | 11 | 2012 | 13 | 0.400 |
Why?
| Receptors, Aryl Hydrocarbon | 2 | 2012 | 51 | 0.390 |
Why?
| Receptors, Notch | 4 | 2015 | 84 | 0.390 |
Why?
| Benzo(a)pyrene | 1 | 2012 | 7 | 0.390 |
Why?
| X-Ray Microtomography | 9 | 2016 | 84 | 0.390 |
Why?
| Staphylococcal Infections | 4 | 2018 | 393 | 0.390 |
Why?
| Trans-Activators | 11 | 2005 | 388 | 0.390 |
Why?
| Hindlimb | 2 | 2011 | 122 | 0.390 |
Why?
| Gene Expression Regulation | 15 | 2017 | 2548 | 0.380 |
Why?
| Collateral Ligaments | 1 | 2011 | 14 | 0.380 |
Why?
| Chickens | 13 | 2012 | 188 | 0.370 |
Why?
| Knee Joint | 4 | 2021 | 371 | 0.360 |
Why?
| Disease Progression | 9 | 2021 | 2635 | 0.350 |
Why?
| Ubiquitin-Protein Ligases | 6 | 2010 | 153 | 0.340 |
Why?
| Receptors, Adrenergic | 2 | 2000 | 34 | 0.330 |
Why?
| Regeneration | 1 | 2011 | 180 | 0.330 |
Why?
| Sciatic Nerve | 2 | 2017 | 56 | 0.330 |
Why?
| Sciatic Neuropathy | 3 | 2019 | 27 | 0.320 |
Why?
| Gene Library | 2 | 2000 | 116 | 0.320 |
Why?
| Parathyroid Hormone | 3 | 2013 | 106 | 0.320 |
Why?
| Adiposity | 1 | 2014 | 504 | 0.320 |
Why?
| Chick Embryo | 11 | 2012 | 130 | 0.320 |
Why?
| Tobacco Smoke Pollution | 1 | 2012 | 231 | 0.310 |
Why?
| Mice, Transgenic | 19 | 2015 | 2119 | 0.310 |
Why?
| Transcription Factor AP-1 | 3 | 2007 | 85 | 0.310 |
Why?
| Proto-Oncogene Proteins | 1 | 2012 | 638 | 0.300 |
Why?
| Cell Cycle Proteins | 4 | 2014 | 586 | 0.290 |
Why?
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 3 | 2013 | 6 | 0.290 |
Why?
| 4-Aminopyridine | 2 | 2019 | 24 | 0.290 |
Why?
| Potassium Channel Blockers | 2 | 2019 | 36 | 0.290 |
Why?
| Osteoblasts | 7 | 2015 | 124 | 0.280 |
Why?
| Bone and Bones | 6 | 2015 | 299 | 0.280 |
Why?
| Regenerative Medicine | 2 | 2022 | 46 | 0.280 |
Why?
| Receptors, Prostaglandin E | 3 | 2009 | 7 | 0.280 |
Why?
| Promoter Regions, Genetic | 8 | 2013 | 1207 | 0.250 |
Why?
| Lymphatic Vessels | 2 | 2019 | 61 | 0.250 |
Why?
| Parathyroid Hormone-Related Protein | 7 | 2005 | 24 | 0.250 |
Why?
| Gene Expression Regulation, Developmental | 9 | 2015 | 821 | 0.250 |
Why?
| Severity of Illness Index | 3 | 2017 | 2742 | 0.240 |
Why?
| Sulfonamides | 2 | 2002 | 496 | 0.240 |
Why?
| Neovascularization, Physiologic | 4 | 2014 | 176 | 0.240 |
Why?
| Up-Regulation | 6 | 2017 | 840 | 0.240 |
Why?
| Meniscus | 2 | 2023 | 21 | 0.240 |
Why?
| Calcium | 7 | 2002 | 1213 | 0.230 |
Why?
| Proteins | 4 | 2003 | 942 | 0.230 |
Why?
| Phosphatidylinositols | 2 | 1994 | 57 | 0.230 |
Why?
| Bone Development | 4 | 2011 | 49 | 0.230 |
Why?
| GTPase-Activating Proteins | 3 | 2014 | 81 | 0.220 |
Why?
| Transcription Factors | 7 | 2008 | 1651 | 0.220 |
Why?
| Limb Buds | 5 | 2010 | 22 | 0.210 |
Why?
| Ligases | 1 | 2003 | 30 | 0.210 |
Why?
| Cardiomegaly | 2 | 2003 | 172 | 0.210 |
Why?
| Calcium Signaling | 2 | 2002 | 250 | 0.210 |
Why?
| Arthritis, Experimental | 2 | 2015 | 128 | 0.210 |
Why?
| Synovial Membrane | 3 | 2019 | 90 | 0.210 |
Why?
| Azacitidine | 1 | 2004 | 139 | 0.200 |
Why?
| Smad Proteins | 6 | 2014 | 38 | 0.200 |
Why?
| Peptide Hormones | 1 | 2002 | 11 | 0.200 |
Why?
| Egtazic Acid | 1 | 2002 | 41 | 0.200 |
Why?
| Wnt Proteins | 4 | 2014 | 127 | 0.200 |
Why?
| Neurodegenerative Diseases | 2 | 2002 | 113 | 0.200 |
Why?
| DNA-Binding Proteins | 7 | 2004 | 1443 | 0.200 |
Why?
| Apoptosis | 6 | 2016 | 2503 | 0.200 |
Why?
| Scleroderma, Systemic | 1 | 2003 | 114 | 0.200 |
Why?
| Intracellular Fluid | 1 | 2002 | 27 | 0.200 |
Why?
| Macrophages | 3 | 2019 | 1480 | 0.200 |
Why?
| Cyclic AMP Response Element-Binding Protein | 5 | 2007 | 141 | 0.200 |
Why?
| Tibial Fractures | 2 | 2014 | 72 | 0.190 |
Why?
| Femur | 3 | 2013 | 244 | 0.190 |
Why?
| Humans | 32 | 2025 | 129652 | 0.190 |
Why?
| Proteoglycans | 4 | 2013 | 110 | 0.190 |
Why?
| Musculoskeletal System | 1 | 2022 | 46 | 0.190 |
Why?
| Male | 21 | 2019 | 63682 | 0.190 |
Why?
| Intercellular Signaling Peptides and Proteins | 4 | 2014 | 375 | 0.180 |
Why?
| Anterior Cruciate Ligament Injuries | 1 | 2023 | 140 | 0.180 |
Why?
| SOX9 Transcription Factor | 2 | 2013 | 24 | 0.180 |
Why?
| Bone Remodeling | 4 | 2014 | 71 | 0.180 |
Why?
| Calcium Phosphates | 2 | 2010 | 22 | 0.180 |
Why?
| Tissue Engineering | 3 | 2022 | 396 | 0.180 |
Why?
| Femoral Fractures | 2 | 2012 | 73 | 0.180 |
Why?
| Matrix Metalloproteinase 13 | 4 | 2019 | 23 | 0.170 |
Why?
| Atrophy | 1 | 2000 | 171 | 0.170 |
Why?
| Cyclic AMP | 5 | 2005 | 237 | 0.170 |
Why?
| Smad1 Protein | 2 | 2011 | 18 | 0.170 |
Why?
| Bone Density | 3 | 2015 | 471 | 0.160 |
Why?
| Hypotension | 1 | 2001 | 116 | 0.160 |
Why?
| Cyclin D1 | 2 | 2012 | 63 | 0.160 |
Why?
| Epoetin Alfa | 1 | 2019 | 6 | 0.160 |
Why?
| Collagen | 1 | 2021 | 434 | 0.160 |
Why?
| Staphylococcus aureus | 3 | 2018 | 438 | 0.160 |
Why?
| Hematinics | 1 | 2019 | 19 | 0.160 |
Why?
| Nerve Compression Syndromes | 1 | 2019 | 23 | 0.160 |
Why?
| Recovery of Function | 2 | 2017 | 642 | 0.160 |
Why?
| Bortezomib | 1 | 2019 | 45 | 0.160 |
Why?
| Proteasome Inhibitors | 1 | 2019 | 42 | 0.150 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2023 | 305 | 0.150 |
Why?
| Body Weight | 5 | 2014 | 940 | 0.150 |
Why?
| Alkaline Phosphatase | 7 | 2011 | 146 | 0.150 |
Why?
| Bifidobacterium longum | 1 | 2018 | 6 | 0.150 |
Why?
| Bone Resorption | 3 | 2015 | 79 | 0.150 |
Why?
| Tissue Scaffolds | 2 | 2010 | 201 | 0.150 |
Why?
| Organ Size | 2 | 2014 | 447 | 0.150 |
Why?
| Immunity, Humoral | 2 | 2018 | 118 | 0.150 |
Why?
| Osteomyelitis | 2 | 2017 | 122 | 0.150 |
Why?
| Aging | 3 | 2019 | 1776 | 0.140 |
Why?
| Germinal Center | 1 | 2018 | 57 | 0.140 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 1998 | 46 | 0.140 |
Why?
| Oligosaccharides | 1 | 2018 | 57 | 0.140 |
Why?
| Osteolysis | 1 | 2018 | 18 | 0.140 |
Why?
| Coagulase | 1 | 2017 | 6 | 0.140 |
Why?
| RANK Ligand | 4 | 2015 | 26 | 0.140 |
Why?
| Foot | 1 | 2018 | 93 | 0.140 |
Why?
| Transforming Growth Factor beta1 | 4 | 2014 | 157 | 0.140 |
Why?
| Prosthesis-Related Infections | 1 | 2018 | 75 | 0.140 |
Why?
| Hydrolysis | 1 | 2017 | 186 | 0.130 |
Why?
| Polymerase Chain Reaction | 1 | 2000 | 1038 | 0.130 |
Why?
| Hedgehog Proteins | 5 | 2004 | 188 | 0.130 |
Why?
| Peripheral Nerve Injuries | 1 | 2016 | 36 | 0.130 |
Why?
| PPAR gamma | 2 | 2015 | 183 | 0.130 |
Why?
| Cysteine-Rich Protein 61 | 1 | 2016 | 5 | 0.130 |
Why?
| Activating Transcription Factor 2 | 3 | 2013 | 5 | 0.130 |
Why?
| Calcium Channels | 1 | 1997 | 164 | 0.130 |
Why?
| Glucose Intolerance | 2 | 2015 | 142 | 0.130 |
Why?
| Osteosarcoma | 2 | 2008 | 72 | 0.130 |
Why?
| Rotator Cuff Injuries | 1 | 2016 | 58 | 0.130 |
Why?
| Transcriptome | 2 | 2022 | 887 | 0.130 |
Why?
| Phenotype | 8 | 2019 | 3076 | 0.120 |
Why?
| Pain | 1 | 2021 | 789 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2016 | 1198 | 0.120 |
Why?
| Gene Expression | 4 | 2014 | 1472 | 0.120 |
Why?
| Receptor, Notch1 | 1 | 2015 | 61 | 0.120 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2010 | 958 | 0.120 |
Why?
| Administration, Oral | 1 | 2017 | 786 | 0.120 |
Why?
| Wound Healing | 2 | 2014 | 306 | 0.120 |
Why?
| Mice, Knockout | 7 | 2014 | 2871 | 0.110 |
Why?
| Bone Morphogenetic Protein 6 | 3 | 2004 | 3 | 0.110 |
Why?
| Osteocalcin | 2 | 2012 | 35 | 0.110 |
Why?
| Bone Regeneration | 1 | 2014 | 23 | 0.110 |
Why?
| Smad2 Protein | 2 | 2012 | 38 | 0.110 |
Why?
| Collagen Type II | 5 | 2013 | 47 | 0.110 |
Why?
| Bone Neoplasms | 2 | 2008 | 231 | 0.110 |
Why?
| Biomechanical Phenomena | 2 | 2014 | 764 | 0.110 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2015 | 182 | 0.110 |
Why?
| Bone Marrow | 1 | 2015 | 271 | 0.110 |
Why?
| Cell Division | 4 | 2004 | 797 | 0.110 |
Why?
| Glycogen Synthase Kinase 3 | 2 | 2014 | 79 | 0.110 |
Why?
| RNA, Messenger | 6 | 2008 | 2708 | 0.100 |
Why?
| Endothelial Cells | 1 | 2019 | 749 | 0.100 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2013 | 71 | 0.100 |
Why?
| Angiopoietin-2 | 1 | 2013 | 15 | 0.100 |
Why?
| Phosphoproteins | 2 | 2014 | 332 | 0.100 |
Why?
| Tendon Injuries | 1 | 2014 | 67 | 0.100 |
Why?
| Extracellular Matrix | 3 | 2013 | 504 | 0.100 |
Why?
| Fractures, Bone | 3 | 2014 | 392 | 0.100 |
Why?
| B-Lymphocytes | 1 | 2018 | 815 | 0.100 |
Why?
| Animals, Newborn | 3 | 2019 | 835 | 0.100 |
Why?
| Tretinoin | 2 | 2003 | 130 | 0.100 |
Why?
| RNA, Small Interfering | 2 | 2012 | 587 | 0.100 |
Why?
| Chelating Agents | 2 | 2002 | 68 | 0.100 |
Why?
| Bone Transplantation | 1 | 2013 | 83 | 0.100 |
Why?
| Intervertebral Disc Degeneration | 1 | 2012 | 33 | 0.100 |
Why?
| Intervertebral Disc Displacement | 1 | 2012 | 39 | 0.100 |
Why?
| Base Sequence | 6 | 2013 | 2142 | 0.100 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2011 | 3 | 0.100 |
Why?
| Time Factors | 5 | 2014 | 6556 | 0.090 |
Why?
| Anabolic Agents | 1 | 2011 | 12 | 0.090 |
Why?
| Serrate-Jagged Proteins | 1 | 2011 | 27 | 0.090 |
Why?
| Osteophyte | 1 | 2011 | 5 | 0.090 |
Why?
| Mast Cells | 1 | 2013 | 142 | 0.090 |
Why?
| Transcriptional Activation | 3 | 2017 | 366 | 0.090 |
Why?
| Mice, Inbred Strains | 2 | 2013 | 406 | 0.090 |
Why?
| Orthopedic Procedures | 1 | 2014 | 210 | 0.090 |
Why?
| Tibial Meniscus Injuries | 1 | 2011 | 45 | 0.090 |
Why?
| Arteries | 1 | 2013 | 265 | 0.090 |
Why?
| Neoplasm Proteins | 2 | 2004 | 424 | 0.090 |
Why?
| bcl-2-Associated X Protein | 2 | 2008 | 55 | 0.090 |
Why?
| Analysis of Variance | 2 | 2017 | 1288 | 0.090 |
Why?
| Bone Substitutes | 1 | 2010 | 25 | 0.090 |
Why?
| Cyclooxygenase 2 | 2 | 2009 | 177 | 0.090 |
Why?
| Histone Deacetylases | 1 | 2012 | 212 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 3 | 2005 | 2012 | 0.090 |
Why?
| RNA Interference | 1 | 2012 | 448 | 0.090 |
Why?
| Calcium-Binding Proteins | 1 | 2011 | 210 | 0.080 |
Why?
| RNA | 1 | 2016 | 883 | 0.080 |
Why?
| Rats | 9 | 2012 | 5500 | 0.080 |
Why?
| Cytoskeletal Proteins | 2 | 2007 | 146 | 0.080 |
Why?
| Dietary Fats | 1 | 2011 | 301 | 0.080 |
Why?
| Stress, Mechanical | 2 | 2010 | 467 | 0.080 |
Why?
| Molecular Sequence Data | 5 | 2004 | 2832 | 0.080 |
Why?
| Osteoporosis | 1 | 2012 | 232 | 0.080 |
Why?
| Isoquinolines | 2 | 2002 | 41 | 0.080 |
Why?
| Lactic Acid | 1 | 2010 | 303 | 0.080 |
Why?
| Blotting, Western | 5 | 2011 | 1205 | 0.080 |
Why?
| Nerve Crush | 1 | 2008 | 5 | 0.080 |
Why?
| Cell Survival | 1 | 2012 | 1086 | 0.080 |
Why?
| Inositol 1,4,5-Trisphosphate | 2 | 2001 | 31 | 0.070 |
Why?
| Weight Gain | 1 | 2011 | 510 | 0.070 |
Why?
| Neural Conduction | 2 | 2019 | 83 | 0.070 |
Why?
| Core Binding Factor Alpha 3 Subunit | 1 | 2007 | 6 | 0.070 |
Why?
| Female | 15 | 2019 | 68777 | 0.070 |
Why?
| Repressor Proteins | 2 | 2008 | 406 | 0.070 |
Why?
| Immunohistochemistry | 2 | 2010 | 1698 | 0.070 |
Why?
| High Mobility Group Proteins | 1 | 2007 | 42 | 0.070 |
Why?
| Protein Isoforms | 2 | 2007 | 391 | 0.070 |
Why?
| Tyrosine | 2 | 2010 | 223 | 0.070 |
Why?
| Ubiquitin | 2 | 2004 | 64 | 0.070 |
Why?
| Biocompatible Materials | 1 | 2010 | 395 | 0.070 |
Why?
| Polymers | 1 | 2010 | 479 | 0.070 |
Why?
| Cell Membrane | 3 | 2001 | 732 | 0.060 |
Why?
| Prazosin | 2 | 2002 | 23 | 0.060 |
Why?
| Stem Cells | 3 | 2022 | 577 | 0.060 |
Why?
| Smad7 Protein | 1 | 2005 | 18 | 0.060 |
Why?
| Cell Proliferation | 5 | 2013 | 2391 | 0.060 |
Why?
| Insulin | 1 | 2016 | 2326 | 0.060 |
Why?
| I-kappa B Kinase | 2 | 2021 | 53 | 0.060 |
Why?
| Enzyme Inhibitors | 3 | 2004 | 827 | 0.060 |
Why?
| Mutagenesis, Site-Directed | 3 | 2008 | 361 | 0.060 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 161 | 0.060 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 474 | 0.060 |
Why?
| Membrane Proteins | 1 | 2011 | 1119 | 0.060 |
Why?
| Radiation Tolerance | 1 | 2005 | 100 | 0.060 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 73 | 0.060 |
Why?
| Environmental Pollutants | 1 | 2007 | 143 | 0.060 |
Why?
| Adrenergic alpha-Antagonists | 2 | 2002 | 33 | 0.060 |
Why?
| Tibia | 2 | 2005 | 170 | 0.060 |
Why?
| Titanium | 1 | 2005 | 77 | 0.060 |
Why?
| Phenylalanine | 2 | 2001 | 65 | 0.050 |
Why?
| Activin Receptors, Type I | 1 | 2003 | 7 | 0.050 |
Why?
| Receptors, Growth Factor | 1 | 2003 | 55 | 0.050 |
Why?
| DNA Primers | 3 | 2013 | 510 | 0.050 |
Why?
| Epinephrine | 2 | 2001 | 141 | 0.050 |
Why?
| Mesoderm | 1 | 2004 | 137 | 0.050 |
Why?
| Cell Line | 3 | 2012 | 2781 | 0.050 |
Why?
| Phosphorylation | 4 | 2010 | 1713 | 0.050 |
Why?
| Protein Kinase C | 1 | 2004 | 259 | 0.050 |
Why?
| Cell Culture Techniques | 2 | 2022 | 345 | 0.050 |
Why?
| Transcription, Genetic | 5 | 2008 | 1418 | 0.050 |
Why?
| Bucladesine | 1 | 2002 | 25 | 0.050 |
Why?
| Annexin A5 | 1 | 2002 | 23 | 0.050 |
Why?
| Nitrates | 1 | 2002 | 89 | 0.050 |
Why?
| Peptide Library | 1 | 2002 | 84 | 0.050 |
Why?
| Carrier Proteins | 2 | 2005 | 743 | 0.050 |
Why?
| Hypertrophy | 1 | 2002 | 121 | 0.050 |
Why?
| Extracellular Space | 1 | 2002 | 120 | 0.050 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 1356 | 0.050 |
Why?
| Gestational Age | 1 | 2005 | 874 | 0.050 |
Why?
| Dihydropyridines | 2 | 2001 | 15 | 0.050 |
Why?
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2001 | 17 | 0.050 |
Why?
| COS Cells | 2 | 2000 | 185 | 0.050 |
Why?
| Paroxetine | 1 | 2021 | 10 | 0.050 |
Why?
| Conserved Sequence | 2 | 2001 | 227 | 0.050 |
Why?
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 9 | 0.050 |
Why?
| Models, Animal | 2 | 2013 | 376 | 0.050 |
Why?
| Heart Septum | 1 | 2001 | 27 | 0.050 |
Why?
| Phenylephrine | 1 | 2001 | 75 | 0.040 |
Why?
| Mole Rats | 1 | 2020 | 5 | 0.040 |
Why?
| Amino Acid Sequence | 3 | 2001 | 2058 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2001 | 154 | 0.040 |
Why?
| Bradycardia | 1 | 2001 | 53 | 0.040 |
Why?
| Substantia Nigra | 1 | 2000 | 56 | 0.040 |
Why?
| Adrenergic alpha-Agonists | 1 | 2000 | 28 | 0.040 |
Why?
| Cloning, Organism | 1 | 1999 | 6 | 0.040 |
Why?
| Complement Activation | 1 | 2023 | 376 | 0.040 |
Why?
| Blood Glucose | 3 | 2015 | 2097 | 0.040 |
Why?
| Norepinephrine | 1 | 2001 | 210 | 0.040 |
Why?
| Imidazoles | 1 | 2001 | 234 | 0.040 |
Why?
| Spleen | 2 | 2015 | 507 | 0.040 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1999 | 150 | 0.040 |
Why?
| Fibroblasts | 1 | 2005 | 948 | 0.040 |
Why?
| Transfection | 3 | 2009 | 911 | 0.040 |
Why?
| 3T3 Cells | 1 | 1999 | 153 | 0.040 |
Why?
| Femoral Artery | 1 | 2001 | 173 | 0.040 |
Why?
| Solutions | 1 | 2000 | 151 | 0.040 |
Why?
| Osteochondrodysplasias | 1 | 2019 | 16 | 0.040 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2019 | 7 | 0.040 |
Why?
| Genes, Reporter | 1 | 1999 | 267 | 0.040 |
Why?
| Lymphangiogenesis | 1 | 2019 | 26 | 0.040 |
Why?
| Models, Biological | 4 | 2010 | 1722 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 399 | 0.040 |
Why?
| Cloning, Molecular | 1 | 2000 | 524 | 0.040 |
Why?
| Gene Deletion | 2 | 2013 | 379 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 2002 | 570 | 0.040 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2019 | 48 | 0.040 |
Why?
| Cell Hypoxia | 1 | 1999 | 235 | 0.040 |
Why?
| Hydrocortisone | 1 | 2001 | 307 | 0.040 |
Why?
| Organ Specificity | 1 | 2019 | 296 | 0.040 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2010 | 8 | 0.040 |
Why?
| Immunoglobulin Class Switching | 1 | 2018 | 19 | 0.040 |
Why?
| Epilepsy | 1 | 2002 | 329 | 0.040 |
Why?
| Decompression, Surgical | 1 | 2019 | 99 | 0.040 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3628 | 0.040 |
Why?
| Coculture Techniques | 1 | 2019 | 226 | 0.040 |
Why?
| Sodium-Hydrogen Exchangers | 1 | 1998 | 26 | 0.040 |
Why?
| Cytidine Deaminase | 1 | 2018 | 57 | 0.040 |
Why?
| Echocardiography | 1 | 2001 | 629 | 0.040 |
Why?
| Cytosol | 2 | 2005 | 218 | 0.040 |
Why?
| Isoproterenol | 1 | 1998 | 115 | 0.040 |
Why?
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2009 | 5 | 0.030 |
Why?
| GTP-Binding Proteins | 1 | 1998 | 157 | 0.030 |
Why?
| Seizures | 1 | 2000 | 402 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 1998 | 372 | 0.030 |
Why?
| Ion Transport | 1 | 1997 | 62 | 0.030 |
Why?
| Myelin P0 Protein | 1 | 2017 | 7 | 0.030 |
Why?
| Adrenergic beta-Agonists | 1 | 1998 | 132 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2000 | 437 | 0.030 |
Why?
| Intermediate Filaments | 1 | 2017 | 27 | 0.030 |
Why?
| Cadmium | 1 | 1997 | 67 | 0.030 |
Why?
| Muscle, Smooth, Vascular | 1 | 1999 | 443 | 0.030 |
Why?
| Heart Rate | 1 | 2001 | 802 | 0.030 |
Why?
| Potassium | 1 | 1997 | 143 | 0.030 |
Why?
| Abscess | 1 | 2017 | 73 | 0.030 |
Why?
| Sternum | 2 | 2009 | 25 | 0.030 |
Why?
| Kinetics | 2 | 1998 | 1642 | 0.030 |
Why?
| Antibodies, Bacterial | 1 | 2017 | 137 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 1 | 1998 | 544 | 0.030 |
Why?
| Antibodies, Neutralizing | 1 | 2019 | 265 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2017 | 426 | 0.030 |
Why?
| Membrane Potentials | 1 | 1997 | 293 | 0.030 |
Why?
| Fibrinogen | 1 | 2017 | 164 | 0.030 |
Why?
| Calcium Channel Blockers | 1 | 1997 | 161 | 0.030 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 274 | 0.030 |
Why?
| Virulence | 1 | 2017 | 255 | 0.030 |
Why?
| Epiphyses | 1 | 2016 | 20 | 0.030 |
Why?
| In Vitro Techniques | 2 | 1995 | 1085 | 0.030 |
Why?
| Cell Separation | 2 | 2015 | 316 | 0.030 |
Why?
| Receptor, IGF Type 2 | 1 | 1995 | 6 | 0.030 |
Why?
| Caspase 3 | 2 | 2008 | 245 | 0.030 |
Why?
| DNA | 1 | 2002 | 1400 | 0.030 |
Why?
| Luciferases | 2 | 2005 | 148 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2010 | 530 | 0.030 |
Why?
| Parkinson Disease | 1 | 2000 | 463 | 0.030 |
Why?
| Leukocyte Common Antigens | 1 | 2015 | 82 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 429 | 0.030 |
Why?
| Oximes | 1 | 2014 | 22 | 0.030 |
Why?
| Shoulder Joint | 1 | 2016 | 164 | 0.030 |
Why?
| Wnt Signaling Pathway | 1 | 2016 | 170 | 0.030 |
Why?
| Smad6 Protein | 2 | 2004 | 2 | 0.030 |
Why?
| Calcification, Physiologic | 2 | 2010 | 34 | 0.030 |
Why?
| Adaptive Immunity | 1 | 2015 | 161 | 0.030 |
Why?
| Tumor Cells, Cultured | 2 | 2005 | 940 | 0.030 |
Why?
| Blood Pressure | 1 | 2001 | 1736 | 0.030 |
Why?
| STAT3 Transcription Factor | 1 | 2015 | 195 | 0.030 |
Why?
| In Situ Hybridization | 2 | 2004 | 295 | 0.030 |
Why?
| Adipocytes | 1 | 2015 | 205 | 0.030 |
Why?
| Age Factors | 1 | 2000 | 3144 | 0.030 |
Why?
| Recombinant Fusion Proteins | 2 | 2009 | 643 | 0.030 |
Why?
| Kidney | 1 | 2001 | 1385 | 0.030 |
Why?
| Receptors, Transforming Growth Factor beta | 2 | 2003 | 56 | 0.030 |
Why?
| Protein Binding | 2 | 2013 | 2121 | 0.030 |
Why?
| Protein Structure, Tertiary | 1 | 2015 | 840 | 0.030 |
Why?
| Hydrodynamics | 1 | 2012 | 40 | 0.030 |
Why?
| ADAMTS5 Protein | 1 | 2012 | 4 | 0.030 |
Why?
| Bioreactors | 1 | 2012 | 43 | 0.030 |
Why?
| Toxicity Tests, Acute | 1 | 2012 | 9 | 0.020 |
Why?
| ADAM Proteins | 1 | 2012 | 59 | 0.020 |
Why?
| Glycoproteins | 1 | 2014 | 338 | 0.020 |
Why?
| Leptin | 1 | 2013 | 219 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2003 | 2061 | 0.020 |
Why?
| Fasting | 1 | 2013 | 267 | 0.020 |
Why?
| Transplantation, Homologous | 1 | 2013 | 401 | 0.020 |
Why?
| Mitochondria, Liver | 1 | 1991 | 74 | 0.020 |
Why?
| Indoles | 1 | 2014 | 387 | 0.020 |
Why?
| Cell Nucleus | 1 | 2014 | 582 | 0.020 |
Why?
| Flow Cytometry | 1 | 2015 | 1156 | 0.020 |
Why?
| Cell Surface Extensions | 1 | 2010 | 13 | 0.020 |
Why?
| Implants, Experimental | 1 | 2010 | 19 | 0.020 |
Why?
| Phospholipase C gamma | 1 | 2010 | 29 | 0.020 |
Why?
| Sodium | 1 | 1991 | 206 | 0.020 |
Why?
| Compressive Strength | 1 | 2010 | 70 | 0.020 |
Why?
| Porosity | 1 | 2010 | 94 | 0.020 |
Why?
| Gene Expression Profiling | 2 | 2011 | 1706 | 0.020 |
Why?
| Transcription Factor HES-1 | 1 | 2010 | 5 | 0.020 |
Why?
| Polyesters | 1 | 2010 | 72 | 0.020 |
Why?
| Cricetinae | 2 | 2001 | 277 | 0.020 |
Why?
| Cell Line, Tumor | 2 | 2008 | 3215 | 0.020 |
Why?
| Trabecular Meshwork | 1 | 2011 | 79 | 0.020 |
Why?
| Swine | 1 | 2012 | 760 | 0.020 |
Why?
| Fibrosis | 1 | 2013 | 520 | 0.020 |
Why?
| src-Family Kinases | 1 | 2010 | 96 | 0.020 |
Why?
| Homeostasis | 1 | 2013 | 611 | 0.020 |
Why?
| Treatment Outcome | 2 | 2016 | 10230 | 0.020 |
Why?
| Surface Properties | 1 | 2010 | 399 | 0.020 |
Why?
| Structure-Activity Relationship | 2 | 2001 | 548 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 68 | 0.020 |
Why?
| Materials Testing | 1 | 2010 | 347 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2010 | 400 | 0.020 |
Why?
| Biomarkers | 2 | 2015 | 3973 | 0.020 |
Why?
| Collagen Type IX | 1 | 2008 | 1 | 0.020 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 237 | 0.020 |
Why?
| Wings, Animal | 1 | 2008 | 38 | 0.020 |
Why?
| Tamoxifen | 1 | 2009 | 200 | 0.020 |
Why?
| Axin Protein | 1 | 2007 | 19 | 0.020 |
Why?
| Insulin Resistance | 1 | 2016 | 1165 | 0.020 |
Why?
| Cholecalciferol | 1 | 2008 | 56 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2010 | 1245 | 0.020 |
Why?
| Response Elements | 1 | 2008 | 90 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2010 | 1206 | 0.020 |
Why?
| Core Binding Factor Alpha 2 Subunit | 1 | 2007 | 33 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2010 | 1304 | 0.020 |
Why?
| Protein Transport | 1 | 2009 | 428 | 0.020 |
Why?
| Lead Poisoning | 1 | 2007 | 19 | 0.020 |
Why?
| Polycyclic Aromatic Hydrocarbons | 1 | 2007 | 27 | 0.020 |
Why?
| Metals, Heavy | 1 | 2007 | 30 | 0.020 |
Why?
| Vitamins | 1 | 2008 | 174 | 0.020 |
Why?
| Radiography | 1 | 2009 | 798 | 0.020 |
Why?
| Transducin | 1 | 2006 | 42 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2010 | 495 | 0.020 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2005 | 49 | 0.020 |
Why?
| Caspase 9 | 1 | 2005 | 56 | 0.020 |
Why?
| Cytochromes c | 1 | 2005 | 60 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 2005 | 81 | 0.020 |
Why?
| Hydrogels | 1 | 2012 | 638 | 0.020 |
Why?
| TCF Transcription Factors | 1 | 2005 | 16 | 0.020 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2005 | 22 | 0.020 |
Why?
| I-kappa B Proteins | 1 | 2005 | 74 | 0.020 |
Why?
| Adenoviridae | 1 | 2006 | 192 | 0.020 |
Why?
| Joint Capsule | 1 | 2005 | 10 | 0.010 |
Why?
| Immunoprecipitation | 1 | 2005 | 157 | 0.010 |
Why?
| Cartilage Diseases | 1 | 2005 | 39 | 0.010 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 37 | 0.010 |
Why?
| Collagenases | 1 | 2004 | 23 | 0.010 |
Why?
| Caspases | 1 | 2005 | 245 | 0.010 |
Why?
| Cell Count | 1 | 2005 | 314 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2016 | 7086 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 2004 | 77 | 0.010 |
Why?
| Embryo, Mammalian | 1 | 2005 | 226 | 0.010 |
Why?
| Skull | 1 | 2005 | 129 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 174 | 0.010 |
Why?
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2003 | 10 | 0.010 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 83 | 0.010 |
Why?
| Receptor Cross-Talk | 1 | 2003 | 21 | 0.010 |
Why?
| Smad5 Protein | 1 | 2003 | 8 | 0.010 |
Why?
| Morphogenesis | 1 | 2004 | 158 | 0.010 |
Why?
| Genes, src | 1 | 2003 | 5 | 0.010 |
Why?
| Cytokine Receptor gp130 | 1 | 2003 | 11 | 0.010 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 287 | 0.010 |
Why?
| Mice, Inbred CBA | 1 | 2003 | 52 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 270 | 0.010 |
Why?
| Synucleins | 1 | 2002 | 7 | 0.010 |
Why?
| Eukaryotic Initiation Factor-3 | 1 | 2002 | 4 | 0.010 |
Why?
| Tartrate-Resistant Acid Phosphatase | 1 | 2002 | 5 | 0.010 |
Why?
| Bacteriophage T7 | 1 | 2002 | 5 | 0.010 |
Why?
| Multiple System Atrophy | 1 | 2002 | 6 | 0.010 |
Why?
| Acid Phosphatase | 1 | 2002 | 20 | 0.010 |
Why?
| Videotape Recording | 1 | 2002 | 34 | 0.010 |
Why?
| Inclusion Bodies | 1 | 2002 | 25 | 0.010 |
Why?
| Two-Hybrid System Techniques | 1 | 2002 | 56 | 0.010 |
Why?
| Smad4 Protein | 1 | 2002 | 38 | 0.010 |
Why?
| Animals, Genetically Modified | 1 | 2003 | 229 | 0.010 |
Why?
| alpha-Synuclein | 1 | 2002 | 32 | 0.010 |
Why?
| Drug Synergism | 1 | 2003 | 371 | 0.010 |
Why?
| Macromolecular Substances | 1 | 2002 | 213 | 0.010 |
Why?
| Down-Regulation | 1 | 2004 | 636 | 0.010 |
Why?
| Cellular Senescence | 1 | 2003 | 181 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2003 | 312 | 0.010 |
Why?
| Isoenzymes | 1 | 2002 | 302 | 0.010 |
Why?
| Oxymetazoline | 1 | 2001 | 2 | 0.010 |
Why?
| Dioxanes | 1 | 2001 | 7 | 0.010 |
Why?
| Clonidine | 1 | 2001 | 27 | 0.010 |
Why?
| Cerebellum | 1 | 2002 | 219 | 0.010 |
Why?
| Oligodendroglia | 1 | 2002 | 166 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 769 | 0.010 |
Why?
| Ephedrine | 1 | 2000 | 4 | 0.010 |
Why?
| Inositol Phosphates | 1 | 2000 | 22 | 0.010 |
Why?
| Antigens, CD | 1 | 2003 | 489 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 2001 | 341 | 0.010 |
Why?
| Electroencephalography | 1 | 2002 | 403 | 0.010 |
Why?
| Spinal Cord | 1 | 2002 | 356 | 0.010 |
Why?
| Sequence Alignment | 1 | 2000 | 332 | 0.010 |
Why?
| Protein-Tyrosine Kinases | 1 | 2003 | 432 | 0.010 |
Why?
| Piperazines | 1 | 2001 | 342 | 0.010 |
Why?
| Models, Chemical | 1 | 2000 | 265 | 0.010 |
Why?
| Survival Rate | 1 | 2002 | 1877 | 0.010 |
Why?
| Motor Activity | 1 | 2002 | 676 | 0.010 |
Why?
| Protein Conformation | 1 | 2000 | 859 | 0.010 |
Why?
| Aged | 1 | 2016 | 22104 | 0.010 |
Why?
| Models, Molecular | 1 | 2001 | 1492 | 0.010 |
Why?
| Stimulation, Chemical | 1 | 1995 | 63 | 0.010 |
Why?
| Blotting, Northern | 1 | 1995 | 200 | 0.010 |
Why?
| Middle Aged | 1 | 2016 | 31155 | 0.010 |
Why?
| Neurons | 1 | 2002 | 1511 | 0.010 |
Why?
| Calorimetry | 1 | 1991 | 66 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1991 | 368 | 0.010 |
Why?
| Pregnancy | 1 | 2004 | 6402 | 0.010 |
Why?
| Fura-2 | 1 | 1990 | 20 | 0.010 |
Why?
| Cell Fractionation | 1 | 1990 | 56 | 0.010 |
Why?
| Brain | 1 | 2002 | 2679 | 0.010 |
Why?
| Organelles | 1 | 1990 | 54 | 0.010 |
Why?
| Adult | 1 | 2008 | 35577 | 0.000 |
Why?
|
|
Zuscik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|